ABT - Abbott Laboratories

NYSE - NYSE Delayed Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
Assets
Current Assets
Cash
Cash And Cash Equivalents
3,844,000
9,407,000
18,620,000
Short Term Investments
242,000
203,000
155,000
Total Cash
4,086,000
9,610,000
18,775,000
Net Receivables
5,182,000
5,249,000
3,248,000
Inventory
3,796,000
3,601,000
2,434,000
Other Current Assets
-
20,000
513,000
Total Current Assets
14,632,000
20,147,000
26,776,000
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
15,706,000
15,265,000
12,366,000
Accumulated Depreciation
-8,143,000
-7,658,000
-6,661,000
Net property, plant and equipment
7,563,000
7,607,000
5,705,000
Equity and other investments
897,000
883,000
2,947,000
Goodwill
23,254,000
24,020,000
7,683,000
Intangible Assets
18,942,000
21,473,000
4,539,000
Other long-term assets
17,000
176,000
2,753,000
Total non-current assets
52,541,000
56,103,000
25,890,000
Total Assets
67,173,000
76,250,000
52,666,000
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
207,000
714,000
1,325,000
Accounts Payable
2,975,000
2,402,000
1,178,000
Taxes payable
305,000
309,000
188,000
Accrued liabilities
4,796,000
4,874,000
3,223,000
Deferred revenues
-
-
-
Other Current Liabilities
-
0
245,000
Total Current Liabilities
9,012,000
8,912,000
6,660,000
Non-current liabilities
Long Term Debt
19,359,000
27,210,000
20,681,000
Deferred taxes liabilities
2,056,000
2,006,000
356,000
Deferred revenues
-
-
-
Other long-term liabilities
3,984,000
4,855,000
2,039,000
Total non-current liabilities
27,439,000
36,240,000
25,289,000
Total Liabilities
36,451,000
45,152,000
31,949,000
Stockholders' Equity
Common Stock
0
0
0
Retained Earnings
24,560,000
23,978,000
25,565,000
Accumulated other comprehensive income
-7,586,000
-6,062,000
-7,263,000
Total stockholders' equity
30,524,000
30,897,000
20,538,000
Total liabilities and stockholders' equity
67,173,000
76,250,000
52,666,000